Research Tier II
The National MPS Society's Research Tier II grant funds focused, mid-scale projects advancing therapies or understanding of mucopolysaccharidosis (MPS) and mucolipidosis (ML).
Funder: National MPS Society
Due Dates: March 13, 2026 (LOI, Cycle I) | May 22, 2026 (Full Proposal, Cycle I) | August 7, 2026 (LOI, Cycle II) | October 2, 2026 (Full Proposal, Cycle II)
Funding Amounts: Up to $50,000 over 1–2 years; one competitive renewal allowed (max $100,000 over 4 years).
Summary: Supports focused, well-defined research projects advancing therapies or understanding of mucopolysaccharidosis (MPS) and mucolipidosis (ML).
Key Information: Only one application per lab per cycle; international and for-profit organizations eligible.
Description
This grant supports targeted, mid-sized research projects that address key challenges in mucopolysaccharidosis (MPS) and mucolipidosis (ML). The focus is on defined research such as drug repurposing, analysis of existing data, or expanding validated therapies to new syndromes. Projects should be well-scoped and achievable within a 1–2 year timeframe, with the possibility of a competitive renewal for an additional period. The goal is to drive meaningful advances in treatment and understanding of MPS and ML.
